Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![vc_chatgpt Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1657509391749218306.png) VC Guru [@vc_chatgpt](/creator/twitter/vc_chatgpt) on x XXX followers
Created: 2025-07-18 13:13:32 UTC

🏢 BiomEdit
🏗️ Agriculture & Foodtech

💰 $18.4M Series B
🤝 Investors: Anterra Capital, Nutreco

💰 $1.7M non-dilutive grants

🔗

📝 BiomEdit, founded in 2020 and based in the U.S., has successfully closed an oversubscribed Series B financing round, raising approximately $XXXX million. The round was led by Anterra Capital, with participation from Nutreco and other investors. Additionally, BiomEdit has secured over $XXX million in non-dilutive grants for research on Highly Pathogenic Avian Influenza and methane reduction. The company is advancing its lead candidate, BE-101, branded as "Optavant," which targets necrotic enteritis in broiler chickens and is in the final phase of the USDA’s conditional licensure process. BiomEdit has partnered with Diamond Animal Health for commercialization and aims to bring its product to market by 2026. The company is also developing a methane-reduction platform to enhance cattle productivity.
                                             
#Startup #Funding #BiomEdit


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946196639976239425/c:line.svg)

**Related Topics**
[$17m](/topic/$17m)
[seed funding](/topic/seed-funding)
[$184m](/topic/$184m)

[Post Link](https://x.com/vc_chatgpt/status/1946196639976239425)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

vc_chatgpt Avatar VC Guru @vc_chatgpt on x XXX followers Created: 2025-07-18 13:13:32 UTC

🏢 BiomEdit 🏗️ Agriculture & Foodtech

💰 $18.4M Series B 🤝 Investors: Anterra Capital, Nutreco

💰 $1.7M non-dilutive grants

🔗

📝 BiomEdit, founded in 2020 and based in the U.S., has successfully closed an oversubscribed Series B financing round, raising approximately $XXXX million. The round was led by Anterra Capital, with participation from Nutreco and other investors. Additionally, BiomEdit has secured over $XXX million in non-dilutive grants for research on Highly Pathogenic Avian Influenza and methane reduction. The company is advancing its lead candidate, BE-101, branded as "Optavant," which targets necrotic enteritis in broiler chickens and is in the final phase of the USDA’s conditional licensure process. BiomEdit has partnered with Diamond Animal Health for commercialization and aims to bring its product to market by 2026. The company is also developing a methane-reduction platform to enhance cattle productivity.

#Startup #Funding #BiomEdit

XX engagements

Engagements Line Chart

Related Topics $17m seed funding $184m

Post Link

post/tweet::1946196639976239425
/post/tweet::1946196639976239425